AvidBiotics Corp.
Biotechnology ResearchCalifornia, United States11-50 Employees
AvidBiotics Corp. is a biotechnology research firm that develops therapeutic proteins capable of selectively destroying target cells, including cancer cells, virus-infected cells, and pathogenic bacteria. The company aims to activate the immune system to recognize and eliminate these diseased cells with high specificity. It is pursuing a new class of narrow-spectrum antibacterial agents designed to treat infections while minimizing disruption to beneficial microbiota. The company is based in South San Francisco, California, and operates as a small to mid-sized team within the regional life sciences ecosystem. Its work covers medical and public health applications, including oncology and infectious diseases, and it has publicly described two proprietary non-antibody protein platforms, Avidocin and Micacide. These platforms reflect a focus on protein-based modalities beyond traditional antibodies to advance therapeutic options.